全文获取类型
收费全文 | 67013篇 |
免费 | 4054篇 |
国内免费 | 1685篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 1960篇 |
妇产科学 | 935篇 |
基础医学 | 4053篇 |
口腔科学 | 102篇 |
临床医学 | 8431篇 |
内科学 | 17873篇 |
皮肤病学 | 105篇 |
神经病学 | 1543篇 |
特种医学 | 4019篇 |
外国民族医学 | 3篇 |
外科学 | 5861篇 |
综合类 | 12352篇 |
现状与发展 | 5篇 |
预防医学 | 3716篇 |
眼科学 | 776篇 |
药学 | 7263篇 |
57篇 | |
中国医学 | 2285篇 |
肿瘤学 | 1285篇 |
出版年
2024年 | 83篇 |
2023年 | 810篇 |
2022年 | 1673篇 |
2021年 | 2371篇 |
2020年 | 2267篇 |
2019年 | 1946篇 |
2018年 | 2027篇 |
2017年 | 1958篇 |
2016年 | 2118篇 |
2015年 | 2154篇 |
2014年 | 4420篇 |
2013年 | 5329篇 |
2012年 | 3870篇 |
2011年 | 4013篇 |
2010年 | 3379篇 |
2009年 | 3248篇 |
2008年 | 3164篇 |
2007年 | 3435篇 |
2006年 | 3046篇 |
2005年 | 2600篇 |
2004年 | 2192篇 |
2003年 | 1941篇 |
2002年 | 1564篇 |
2001年 | 1553篇 |
2000年 | 1284篇 |
1999年 | 1109篇 |
1998年 | 948篇 |
1997年 | 944篇 |
1996年 | 775篇 |
1995年 | 847篇 |
1994年 | 740篇 |
1993年 | 525篇 |
1992年 | 517篇 |
1991年 | 433篇 |
1990年 | 386篇 |
1989年 | 338篇 |
1988年 | 335篇 |
1987年 | 294篇 |
1986年 | 256篇 |
1985年 | 337篇 |
1984年 | 299篇 |
1983年 | 123篇 |
1982年 | 223篇 |
1981年 | 191篇 |
1980年 | 190篇 |
1979年 | 122篇 |
1978年 | 92篇 |
1977年 | 90篇 |
1976年 | 71篇 |
1974年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
《Gaceta sanitaria / S.E.S.P.A.S》2015,29(5):390-392
Chronic obstructive pulmonary disease (COPD) is a significant health problem in developed countries. We aimed to estimate the prevalence of COPD in a single Spanish healthcare area. We also aimed to assess if there are any differences in prevalence and spirometry use among primary care services by utilizing already registered information. We designed a cross-sectional study to determine the prevalence of COPD and the performance of spirometries in each primary care service. A total of 8,444 patients were diagnosed with COPD, with a prevalence of 2.6% for individuals older than 39 years. The prevalence increased with age and was much higher in men. Significant heterogeneity was found in the prevalence of COPD and spirometry use among primary care services. COPD was underdiagnosed and there was wide variability in spirometry use in our area. Greater efforts are needed to diagnose COPD in order to improve its clinical outcomes and to refine registries so that they can be used as reliable sources of information 相似文献
24.
25.
《Diagnostic and interventional imaging》2021,102(10):641-648
PurposeTo evaluate the potential differences in non-target embolization and vessel microsphere filling of a reflux-control microcatheter (RCM) compared to a standard end-hole microcatheter (SEHM) in a swine model.Materials and methodsRadiopaque microspheres were injected with both RCM and SEHM (2.4-Fr and 2.7-Fr) in the kidneys of a preclinical swine model. Transarterial renal embolization procedures with RCM or SEHM were performed in both kidneys of 14 pigs. Renal arteries were selectively embolized with an automated injection protocol of radio-opaque microspheres. Ex-vivo X-ray microtomography images of the kidneys were utilized to evaluate the embolization by quantification of the deposition of injected microspheres in the target vs. the non-target area of injection. X-ray microtomography images were blindly analyzed by five interventional radiologists. The degree of vessel filling and the non-target embolization were quantified using a scale from 1 to 5 for each parameter. An analysis of variance was used to compare the paired scores.ResultsTotal volumes of radio-opaque microspheres injected were similar for RCM (11.5 ± 3.6 [SD] mL; range: 6–17 mL) and SEHM (10.6 ± 5.2 [SD] mL; range: 4–19 mL) (P = 0.38). The voxels enhanced ratio in the target (T) vs. non-target (NT) areas was greater with RCM (T = 98.3% vs. NT = 1.7%) than with SEHM (T = 89% vs. NT = 11%) but the difference was not significant (P = 0.30). The total score blindly given by the five interventional radiologists was significantly different between RCM (12.3 ± 2.1 [SD]; range: 6–15) and the standard catheter (11.3 ± 2.5 [SD]; range: 4–15) (P = 0.0073), with a significant decrease of non-target embolization for RCM (3.8 ± 1.3 [SD]; range: 3.5–4.2) compared to SEHM (3.2 ± 1.5 [SD]; range: 2.9–3.5) (P = 0.014).ConclusionIn an animal model, RCM microcatheters reduce the risk of non-target embolization from 11% to 1.7%, increasing the delivery of microspheres of 98% to the target vessels, compared to SEHM microcatheters. 相似文献
26.
28.
29.
BackgroundComplete surgical removal is currently considered to be the best treatment option for pulmonary sarcomatoid carcinoma (PSC) especially in early stage operable disease; however, the reported recurrence-free survival is low. Benefits of adjuvant chemotherapy in PSC patients are still controversial, and there is no obvious agreement on the optimal treatment modalities of this disease. Therefore, we aimed to investigate the prognosis in terms of overall survival (OS) in patients with PSC who received adjuvant chemotherapy.MethodsThe review protocol was registered in PROSPERO (CRD42022306084). Patients with PSC who underwent surgical therapy with or without adjuvant chemotherapy were included into the meta-analysis. Hazard ratios (HR) with 95% confidence intervals (CIs) for OS were pooled and ROBINS-I tool was used to assess risk of bias of the included studies.ResultsWe identified four retrospective cohort studies with 6768 records from MEDLINE, Embase, and CENTRAL databases up to 9th September 2021, and altogether 1835 patients were included to the analysis. The present meta-analysis shows that patients receiving adjuvant chemotherapy had a significantly longer OS than patients who underwent surgical treatment alone (HR = 0.5657, 95%CI: 0.4391–0.7290, p < 0.0001).ConclusionsDespite the limited information on the chemotherapy regimens in the included studies, patients with PSC may benefit from adjuvant chemotherapy. More publications are required to evaluate and compare efficient adjuvant chemotherapy protocols in PSC cases. 相似文献